chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Nausea, Pain, Pyrexia
Clinical narrative: Flu-like symptoms; 3 days of body aches; Nausea; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (3 days of body aches), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Fever). an unknown date, the patient experienced PAIN (3 days of body aches). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (3 days of body aches), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Fatigue, Headache, Influenza like illness
Clinical narrative: Covid arm; Itchy at injection site; Swollen at injection site; Flu like symptoms; Nausea; Tired; Headache; Achy; Weakness; Stomachache; This spontaneous case was reported by a health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE REACTION (Covid arm), PAIN (Achy), ASTHENIA (Weakness) and ABDOMINAL PAIN UPPER (Stomachache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Achy), ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (Nausea), FATIGUE (Tired) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swollen at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 24-Feb-2021, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swollen at injection site) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Achy), ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (Nausea), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Covid arm; Itchy at injection site; Swollen at injection site; Flu like symptoms; Nausea; Tired; Headache; Achy; Weakness; Stomachache; This spontaneous case was reported by a health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE REACTION (Covid arm), PAIN (Achy), ASTHENIA (Weakness) and ABDOMINAL PAIN UPPER (Stomachache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Achy), ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (Nausea), FATIGUE (Tired) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swollen at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 24-Feb-2021, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE SWELLING (Swollen at injection site) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Achy), ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomachache), NAUSEA (Nausea), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: .  On an unspecified date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an 23 Feb 2021, one day prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 002A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 24 Feb 2021, the patient experienced the event(s) dizziness, nausea, vomiting.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was considered to be not applicable.   The outcome of event(s), dizziness, nausea, vomiting was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm is sore at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE PAIN (Arm is sore at the injection site). At the time of the report, INJECTION SITE PAIN (Arm is sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was provided. Patient treatment information was no provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site warmth, Pyrexia, Vaccination site induration
Clinical narrative: Warm to the touch at the site of injection; Red sore knot at the injection site; Red sore knot at the injection site; Headache; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE INDURATION (Red sore knot at the injection site), INJECTION SITE ERYTHEMA (Red sore knot at the injection site), HEADACHE (Headache) and PYREXIA (Low grade fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 91M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE INDURATION (Red sore knot at the injection site), INJECTION SITE ERYTHEMA (Red sore knot at the injection site), HEADACHE (Headache) and PYREXIA (Low grade fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE INDURATION (Red sore knot at the injection site), INJECTION SITE ERYTHEMA (Red sore knot at the injection site), HEADACHE (Headache) and PYREXIA (Low grade fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Vaccine leaked out of syringe, patient received deviation from normal dose; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Vaccine leaked out of syringe, patient received deviation from normal dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 25-Feb-2021, the patient experienced UNDERDOSE (Vaccine leaked out of syringe, patient received deviation from normal dose). At the time of the report, UNDERDOSE (Vaccine leaked out of syringe, patient received deviation from normal dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.   Reporter did not allow further contact
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Joint swelling, Pyrexia
Clinical narrative: "Nut" on the elbow after getting the second dose of Moderna COVID-19; High temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING ("Nut" on the elbow after getting the second dose of Moderna COVID-19), PYREXIA (High temperature) and CHILLS (Chills) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027620A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced JOINT SWELLING ("Nut" on the elbow after getting the second dose of Moderna COVID-19), PYREXIA (High temperature) and CHILLS (Chills). At the time of the report, JOINT SWELLING ("Nut" on the elbow after getting the second dose of Moderna COVID-19), PYREXIA (High temperature) and CHILLS (Chills) had resolved.            No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: The follow up received contain significant information :outcome of the events changed from unknown to recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site rash
Clinical narrative: 2 week later,light pink around injection site; Developing a rash and redness spreading; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (2 week later,light pink around injection site) and VACCINATION SITE RASH (Developing a rash and redness spreading) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SACUBITRIL VALSARTAN SODIUM HYDRATE (ENTRESTO) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (2 week later,light pink around injection site) and VACCINATION SITE RASH (Developing a rash and redness spreading). At the time of the report, VACCINATION SITE DISCOLOURATION (2 week later,light pink around injection site) and VACCINATION SITE RASH (Developing a rash and redness spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Thyroid pill.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Paraesthesia
Clinical narrative: pins and needles/tingling all over her body that have not stopped; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (pins and needles/tingling all over her body that have not stopped) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PARAESTHESIA (pins and needles/tingling all over her body that have not stopped). At the time of the report, PARAESTHESIA (pins and needles/tingling all over her body that have not stopped) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: other Other.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: itches really bad; warmness at the injection site; 1 inch and half wide by 3 inches long at injection site welt and redness at injection site; Redness at injection site; arm swelled up; Broad lump that was hard at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itches really bad), INJECTION SITE MASS (Broad lump that was hard at the injection site), INJECTION SITE WARMTH (warmness at the injection site), INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE SWELLING (arm swelled up) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced INJECTION SITE MASS (Broad lump that was hard at the injection site), INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE SWELLING (arm swelled up). On 26-Feb-2021, the patient experienced PRURITUS (itches really bad), INJECTION SITE WARMTH (warmness at the injection site) and INJECTION SITE ERYTHEMA (1 inch and half wide by 3 inches long at injection site welt and redness at injection site). On 21-Feb-2021, INJECTION SITE MASS (Broad lump that was hard at the injection site) and INJECTION SITE ERYTHEMA (Redness at injection site) had resolved, INJECTION SITE SWELLING (arm swelled up) outcome was unknown. At the time of the report, PRURITUS (itches really bad), INJECTION SITE WARMTH (warmness at the injection site) and INJECTION SITE ERYTHEMA (1 inch and half wide by 3 inches long at injection site welt and redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Treatment included Aloe vera
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Chills, Fatigue, Nausea
Clinical narrative: pain in underarm; chest pain; Soreness in her arm; Chills; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in underarm), PAIN IN EXTREMITY (Soreness in her arm), CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pulmonary edema. Concurrent medical conditions included Diabetes mellitus, Hypertension, Hyperlipidemia, Allergy to molds, Dust allergy and Drug allergy (Amoxicillin, sulfa drugs, Zestril, actos, Avandia, most statins). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), INSULIN LISPRO (HUMALOG), INSULIN GLARGINE (LANTUS) and FUROSEMIDE (LASIX [FUROSEMIDE]) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm) and CHILLS (Chills). 10-Feb-2021, the patient experienced NAUSEA (Nausea) and FATIGUE (Fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in underarm) and CHEST PAIN (chest pain). The patient was treated with PREDNISONE for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in underarm), PAIN IN EXTREMITY (Soreness in her arm), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue) and CHEST PAIN (chest pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive (Positive) Positive.         This case was linked to MOD-2021-026807 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: significant follow up, event added On 28-Apr-2021: Non significant follow up
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in underarm; chest pain; Soreness in her arm; Chills; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in underarm), PAIN IN EXTREMITY (Soreness in her arm), CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pulmonary edema. Concurrent medical conditions included Diabetes mellitus, Hypertension, Hyperlipidemia, Allergy to molds, Dust allergy and Drug allergy (Amoxicillin, sulfa drugs, Zestril, actos, Avandia, most statins). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), INSULIN LISPRO (HUMALOG), INSULIN GLARGINE (LANTUS) and FUROSEMIDE (LASIX [FUROSEMIDE]) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm) and CHILLS (Chills). 10-Feb-2021, the patient experienced NAUSEA (Nausea) and FATIGUE (Fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in underarm) and CHEST PAIN (chest pain). The patient was treated with PREDNISONE for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in underarm), PAIN IN EXTREMITY (Soreness in her arm), CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue) and CHEST PAIN (chest pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive (Positive) Positive.         This case was linked to MOD-2021-026807 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: significant follow up, event added On 28-Apr-2021: Non significant follow up
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (a little soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Thyroid disorder NOS.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (a little soreness). On 25-Feb-2021, VACCINATION SITE PAIN (a little soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medication includes blood pressure and thyroid. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Serum sickness
Clinical narrative: suspected serum reaction to COVID vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SERUM SICKNESS (suspected serum reaction to COVID vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SERUM SICKNESS (suspected serum reaction to COVID vaccine). At the time of the report, SERUM SICKNESS (suspected serum reaction to COVID vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: Shortness of breath; Coughing; Sore throat; Some Fever; Vomiting; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Shortness of breath), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Some Fever) and VOMITING (Vomiting) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Some Fever), VOMITING (Vomiting) and HEADACHE (Headache). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 4 mg. At the time of the report, DYSPNOEA (Shortness of breath), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Some Fever), VOMITING (Vomiting) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment details included drug to stop the vomiting. Zofran. Hydration. Injection.
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Shortness of breath; Coughing; Sore throat; Some Fever; Vomiting; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Shortness of breath), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Some Fever) and VOMITING (Vomiting) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Some Fever), VOMITING (Vomiting) and HEADACHE (Headache). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 4 mg. At the time of the report, DYSPNOEA (Shortness of breath), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Some Fever), VOMITING (Vomiting) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment details included drug to stop the vomiting. Zofran. Hydration. Injection.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain in extremity, Palpitations
Clinical narrative: Felt foggy and couldn't think clear; Sore arm; Racing heart; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Racing heart), FEELING ABNORMAL (Felt foggy and couldn't think clear) and PAIN IN EXTREMITY (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PALPITATIONS (Racing heart). On an unknown date, the patient experienced FEELING ABNORMAL (Felt foggy and couldn't think clear) and PAIN IN EXTREMITY (Sore arm). At the time of the report, PALPITATIONS (Racing heart), FEELING ABNORMAL (Felt foggy and couldn't think clear) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Paraesthesia, Vaccination site erythema, Vaccination site induration, Vaccination site pain
Clinical narrative: Reaction had a diameter of 6 inches and went up her shoulder; Tingling into her fingers; itchy/Itchiness; Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy; Arm was sore/Extremely Painful; Hardness and a red circle around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Reaction had a diameter of 6 inches and went up her shoulder), PARAESTHESIA (Tingling into her fingers), VACCINATION SITE PRURITUS (itchy/Itchiness), VACCINATION SITE INDURATION (Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy) and VACCINATION SITE PAIN (Arm was sore/Extremely Painful) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Reaction had a diameter of 6 inches and went up her shoulder), PARAESTHESIA (Tingling into her fingers), VACCINATION SITE PRURITUS (itchy/Itchiness), VACCINATION SITE INDURATION (Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy), VACCINATION SITE PAIN (Arm was sore/Extremely Painful) and VACCINATION SITE ERYTHEMA (Hardness and a red circle around the injection site). At the time of the report, ADVERSE REACTION (Reaction had a diameter of 6 inches and went up her shoulder), PARAESTHESIA (Tingling into her fingers), VACCINATION SITE PRURITUS (itchy/Itchiness), VACCINATION SITE INDURATION (Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy), VACCINATION SITE PAIN (Arm was sore/Extremely Painful) and VACCINATION SITE ERYTHEMA (Hardness and a red circle around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Reaction had a diameter of 6 inches and went up her shoulder; Tingling into her fingers; itchy/Itchiness; Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy; Arm was sore/Extremely Painful; Hardness and a red circle around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Reaction had a diameter of 6 inches and went up her shoulder), PARAESTHESIA (Tingling into her fingers), VACCINATION SITE PRURITUS (itchy/Itchiness), VACCINATION SITE INDURATION (Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy) and VACCINATION SITE PAIN (Arm was sore/Extremely Painful) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Reaction had a diameter of 6 inches and went up her shoulder), PARAESTHESIA (Tingling into her fingers), VACCINATION SITE PRURITUS (itchy/Itchiness), VACCINATION SITE INDURATION (Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy), VACCINATION SITE PAIN (Arm was sore/Extremely Painful) and VACCINATION SITE ERYTHEMA (Hardness and a red circle around the injection site). At the time of the report, ADVERSE REACTION (Reaction had a diameter of 6 inches and went up her shoulder), PARAESTHESIA (Tingling into her fingers), VACCINATION SITE PRURITUS (itchy/Itchiness), VACCINATION SITE INDURATION (Patient has hardness and a red circle around the injection site, itchiness and tingling into her fingers. She states that her arm was sore, extremely painful and itchy), VACCINATION SITE PAIN (Arm was sore/Extremely Painful) and VACCINATION SITE ERYTHEMA (Hardness and a red circle around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, ARTHRALGIA (Joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain, Pyrexia
Clinical narrative: Pains; Aches; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pains), MYALGIA (Aches), HEADACHE (Headache) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (Pains), MYALGIA (Aches), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, PAIN (Pains), MYALGIA (Aches), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided. Concomitant medication list was not provided by the reporter. Treatment information was not provided.   The reporter wanted to know if ibuprofen, aspirin or anything could be taken to alleviate the pain.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Hard lump injection site; warm to the touch injection site; itchy injection site; Rash injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Hard lump injection site), INJECTION SITE WARMTH (warm to the touch injection site), INJECTION SITE PRURITUS (itchy injection site) and INJECTION SITE RASH (Rash injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INJECTION SITE MASS (Hard lump injection site), INJECTION SITE WARMTH (warm to the touch injection site), INJECTION SITE PRURITUS (itchy injection site) and INJECTION SITE RASH (Rash injection site). At the time of the report, INJECTION SITE MASS (Hard lump injection site), INJECTION SITE WARMTH (warm to the touch injection site), INJECTION SITE PRURITUS (itchy injection site) and INJECTION SITE RASH (Rash injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: itchiness on site of injection; soreness on site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness on site of injection) and VACCINATION SITE PAIN (soreness on site of injection) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness on site of injection) and VACCINATION SITE PAIN (soreness on site of injection). On 06-Feb-2021, VACCINATION SITE PRURITUS (itchiness on site of injection) and VACCINATION SITE PAIN (soreness on site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Malaise, Swelling
Clinical narrative: On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), MALAISE (Didn't feel very well) and SWELLING (Swelling). At the time of the report, DIZZINESS (Dizziness), MALAISE (Didn't feel very well) and SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication  includes medicines for asthma. Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Severe itching in different places of her body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Severe itching in different places of her body) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PRURITUS (Severe itching in different places of her body). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Severe itching in different places of her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Fatigue, Headache, Nausea
Clinical narrative: Chronic fatigue, feels exhausted; Nausea; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FATIGUE (Chronic fatigue, feels exhausted) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Reflex sympathetic dystrophy on 16-Feb-2011 and Pneumonia (occurred 17 times in the past). Concurrent medical conditions included Drug allergy (codeine,keflex), Allergy to chemicals (Sulphur,nickel), Tachycardia, Thyroid pain since 1982 and Migraine since 1999. Concomitant products included METOPROLOL, GABAPENTIN, MONTELUKAST, CYCLOBENZAPRINE, HCTZ, LOSARTAN POTASSIUM, PROGESTERONE, LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) and ESTRADIOL for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Chronic fatigue, feels exhausted). At the time of the report, FATIGUE (Chronic fatigue, feels exhausted) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: negative (Negative) negative for antibodies..         No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-027078 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Updated medical history, concomitant medications. Event headache outcome was changed from unknown to not recovered. On 25-May-2021: Added lab data and event fatigue.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.            No concomitant provided. Patient treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: TCR Received: and contains no new information
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nasopharyngitis, Nausea, Pain, Rhinorrhoea
Clinical narrative: nausea, aching, runny nose, loose stool, instantly have cold; nausea, aching, runny nose, loose stool, instantly have cold; nausea, aching, runny nose, loose stool, instantly have cold; nausea, aching, runny nose, loose stool, instantly have cold; nausea, aching, runny nose, loose stool, instantly have cold; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea, aching, runny nose, loose stool, instantly have cold), PAIN (nausea, aching, runny nose, loose stool, instantly have cold), RHINORRHOEA (nausea, aching, runny nose, loose stool, instantly have cold), DIARRHOEA (nausea, aching, runny nose, loose stool, instantly have cold) and NASOPHARYNGITIS (nausea, aching, runny nose, loose stool, instantly have cold) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced NAUSEA (nausea, aching, runny nose, loose stool, instantly have cold), PAIN (nausea, aching, runny nose, loose stool, instantly have cold) and NASOPHARYNGITIS (nausea, aching, runny nose, loose stool, instantly have cold). On an unknown date, the patient experienced RHINORRHOEA (nausea, aching, runny nose, loose stool, instantly have cold) and DIARRHOEA (nausea, aching, runny nose, loose stool, instantly have cold). At the time of the report, NAUSEA (nausea, aching, runny nose, loose stool, instantly have cold), PAIN (nausea, aching, runny nose, loose stool, instantly have cold), RHINORRHOEA (nausea, aching, runny nose, loose stool, instantly have cold), DIARRHOEA (nausea, aching, runny nose, loose stool, instantly have cold) and NASOPHARYNGITIS (nausea, aching, runny nose, loose stool, instantly have cold) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: severe leg pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe leg pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN IN EXTREMITY (severe leg pain). At the time of the report, PAIN IN EXTREMITY (severe leg pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: severe leg pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe leg pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN IN EXTREMITY (severe leg pain). At the time of the report, PAIN IN EXTREMITY (severe leg pain) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Exhausted only after the second dose ("flat in the bed"); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Exhausted only after the second dose ("flat in the bed")) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 004M20A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Patient has multiple cancers.), Neuropathy since an unknown date, Shoulder dislocation (both shoulders dislocated) and Surgery (Patient had 10 heart surgeries (the 11th was cancelled by HCP because it was "too risky"),). Concurrent medical conditions included Diabetes (diabetic type 2) and Allergy (Patient has allergy to flu shots (last one was given on 1954).). Concomitant products included INSULIN for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced FATIGUE (Exhausted only after the second dose ("flat in the bed")). On 26-Feb-2021, FATIGUE (Exhausted only after the second dose ("flat in the bed")) had resolved.            Concomitant medications reported include, Blood thinners.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: TCR received and contains no new information.